Research ArticleArticle
Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362
Alex Man Lai Wu
Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).
Pooja Dalvi
Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).
Xiaoli Lu
Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).
Mingdong Yang
Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).
David S. Riddick
Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).
Jason Matthews
Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).
Charles V. Clevenger
Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).
Douglas D. Ross
Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).
Patricia A. Harper
Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).
Shinya Ito
Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Prolactin induces multidrug resistance transporter ABCG2
Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
Molecular Pharmacology February 1, 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362
Research ArticleArticle
Prolactin induces multidrug resistance transporter ABCG2
Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
Molecular Pharmacology February 1, 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement